DORMAN PRODUCTS INC (DORM) Fundamental Analysis & Valuation

NASDAQ:DORM • US2582781009

116.16 USD
-0.06 (-0.05%)
At close: Mar 4, 2026
116 USD
-0.16 (-0.14%)
Pre-Market: 3/5/2026, 5:40:35 AM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This DORM fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

6

Overall DORM gets a fundamental rating of 6 out of 10. We evaluated DORM against 41 industry peers in the Automobile Components industry. While DORM has a great profitability rating, there are some minor concerns on its financial health. DORM is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

9

1. DORM Profitability Analysis

1.1 Basic Checks

  • DORM had positive earnings in the past year.
  • In the past year DORM had a positive cash flow from operations.
  • Of the past 5 years DORM 4 years were profitable.
  • DORM had a positive operating cash flow in 4 of the past 5 years.
DORM Yearly Net Income VS EBIT VS OCF VS FCFDORM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

1.2 Ratios

  • DORM has a better Return On Assets (9.70%) than 90.24% of its industry peers.
  • DORM has a Return On Equity of 16.70%. This is amongst the best in the industry. DORM outperforms 92.68% of its industry peers.
  • The Return On Invested Capital of DORM (13.16%) is better than 90.24% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for DORM is in line with the industry average of 9.17%.
  • The last Return On Invested Capital (13.16%) for DORM is above the 3 year average (9.34%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 9.7%
ROE 16.7%
ROIC 13.16%
ROA(3y)6.22%
ROA(5y)7.06%
ROE(3y)12.47%
ROE(5y)12.81%
ROIC(3y)9.34%
ROIC(5y)9.92%
DORM Yearly ROA, ROE, ROICDORM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

  • DORM has a Profit Margin of 11.65%. This is amongst the best in the industry. DORM outperforms 97.56% of its industry peers.
  • DORM's Profit Margin has improved in the last couple of years.
  • Looking at the Operating Margin, with a value of 16.71%, DORM belongs to the top of the industry, outperforming 97.56% of the companies in the same industry.
  • DORM's Operating Margin has improved in the last couple of years.
  • The Gross Margin of DORM (41.88%) is better than 85.37% of its industry peers.
  • In the last couple of years the Gross Margin of DORM has grown nicely.
Industry RankSector Rank
OM 16.71%
PM (TTM) 11.65%
GM 41.88%
OM growth 3Y4.55%
OM growth 5Y6.44%
PM growth 3Y-1.1%
PM growth 5Y2.27%
GM growth 3Y5.26%
GM growth 5Y3.2%
DORM Yearly Profit, Operating, Gross MarginsDORM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. DORM Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), DORM is creating some value.
  • DORM has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
DORM Yearly Shares OutstandingDORM Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
DORM Yearly Total Debt VS Total AssetsDORM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

  • An Altman-Z score of 4.47 indicates that DORM is not in any danger for bankruptcy at the moment.
  • DORM has a Altman-Z score of 4.47. This is amongst the best in the industry. DORM outperforms 82.93% of its industry peers.
  • DORM has a debt to FCF ratio of 4.33. This is a neutral value as DORM would need 4.33 years to pay back of all of its debts.
  • With a decent Debt to FCF ratio value of 4.33, DORM is doing good in the industry, outperforming 70.73% of the companies in the same industry.
  • DORM has a Debt/Equity ratio of 0.28. This is a healthy value indicating a solid balance between debt and equity.
  • DORM's Debt to Equity ratio of 0.28 is fine compared to the rest of the industry. DORM outperforms 63.41% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.28
Debt/FCF 4.33
Altman-Z 4.47
ROIC/WACC1.48
WACC8.9%
DORM Yearly LT Debt VS Equity VS FCFDORM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.3 Liquidity

  • A Current Ratio of 2.94 indicates that DORM has no problem at all paying its short term obligations.
  • With a decent Current ratio value of 2.94, DORM is doing good in the industry, outperforming 73.17% of the companies in the same industry.
  • A Quick Ratio of 1.19 indicates that DORM should not have too much problems paying its short term obligations.
  • DORM has a Quick ratio (1.19) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 2.94
Quick Ratio 1.19
DORM Yearly Current Assets VS Current LiabilitesDORM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. DORM Growth Analysis

3.1 Past

  • DORM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 24.23%, which is quite impressive.
  • DORM shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 20.72% yearly.
EPS 1Y (TTM)24.23%
EPS 3Y23.06%
EPS 5Y20.72%
EPS Q2Q%-1.36%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%0.78%

3.2 Future

  • Based on estimates for the next years, DORM will show a small growth in Earnings Per Share. The EPS will grow by 6.46% on average per year.
  • The Revenue is expected to grow by 5.64% on average over the next years.
EPS Next Y0.95%
EPS Next 2Y5.42%
EPS Next 3Y-0.14%
EPS Next 5Y6.46%
Revenue Next Year5.43%
Revenue Next 2Y5.1%
Revenue Next 3Y5.65%
Revenue Next 5Y5.64%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
DORM Yearly Revenue VS EstimatesDORM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B 2B 2.5B
DORM Yearly EPS VS EstimatesDORM Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

4

4. DORM Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 13.10 indicates a correct valuation of DORM.
  • Based on the Price/Earnings ratio, DORM is valued a bit cheaper than 65.85% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of DORM to the average of the S&P500 Index (27.03), we can say DORM is valued rather cheaply.
  • Based on the Price/Forward Earnings ratio of 12.97, the valuation of DORM can be described as correct.
  • DORM's Price/Forward Earnings is on the same level as the industry average.
  • DORM's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 25.11.
Industry RankSector Rank
PE 13.1
Fwd PE 12.97
DORM Price Earnings VS Forward Price EarningsDORM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • The rest of the industry has a similar Enterprise Value to EBITDA ratio as DORM.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of DORM is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 33.33
EV/EBITDA 9.5
DORM Per share dataDORM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates DORM does not grow enough to justify the current Price/Earnings ratio.
  • DORM has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)13.84
PEG (5Y)0.63
EPS Next 2Y5.42%
EPS Next 3Y-0.14%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. DORM Dividend Analysis

5.1 Amount

  • DORM does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

DORM Fundamentals: All Metrics, Ratios and Statistics

DORMAN PRODUCTS INC

NASDAQ:DORM (3/4/2026, 8:20:23 PM)

Premarket: 116 -0.16 (-0.14%)

116.16

-0.06 (-0.05%)

Chartmill FA Rating
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)02-25
Earnings (Next)05-04
Inst Owners87.15%
Inst Owner Change0.85%
Ins Owners13.6%
Ins Owner Change0.38%
Market Cap3.51B
Revenue(TTM)N/A
Net Income(TTM)247.63M
Analysts82.86
Price Target173.78 (49.6%)
Short Float %4.2%
Short Ratio5.5
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.25%
Min EPS beat(2)2.92%
Max EPS beat(2)11.58%
EPS beat(4)4
Avg EPS beat(4)15.07%
Min EPS beat(4)2.92%
Max EPS beat(4)36.11%
EPS beat(8)8
Avg EPS beat(8)23.63%
EPS beat(12)8
Avg EPS beat(12)10.09%
EPS beat(16)9
Avg EPS beat(16)7.08%
Revenue beat(2)1
Avg Revenue beat(2)-0.17%
Min Revenue beat(2)-3.26%
Max Revenue beat(2)2.92%
Revenue beat(4)2
Avg Revenue beat(4)0.68%
Min Revenue beat(4)-3.26%
Max Revenue beat(4)3.34%
Revenue beat(8)2
Avg Revenue beat(8)-0.93%
Revenue beat(12)3
Avg Revenue beat(12)-0.87%
Revenue beat(16)6
Avg Revenue beat(16)0.21%
PT rev (1m)-1.8%
PT rev (3m)-1.8%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.16%
EPS NY rev (1m)-0.04%
EPS NY rev (3m)0.02%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.05%
Valuation
Industry RankSector Rank
PE 13.1
Fwd PE 12.97
P/S 1.65
P/FCF 33.33
P/OCF 24.52
P/B 2.36
P/tB 4.51
EV/EBITDA 9.5
EPS(TTM)8.87
EY7.64%
EPS(NY)8.95
Fwd EY7.71%
FCF(TTM)3.48
FCFY3%
OCF(TTM)4.74
OCFY4.08%
SpS70.45
BVpS49.12
TBVpS25.73
PEG (NY)13.84
PEG (5Y)0.63
Graham Number99.02
Profitability
Industry RankSector Rank
ROA 9.7%
ROE 16.7%
ROCE 17.45%
ROIC 13.16%
ROICexc 13.53%
ROICexgc 21.03%
OM 16.71%
PM (TTM) 11.65%
GM 41.88%
FCFM 4.95%
ROA(3y)6.22%
ROA(5y)7.06%
ROE(3y)12.47%
ROE(5y)12.81%
ROIC(3y)9.34%
ROIC(5y)9.92%
ROICexc(3y)9.58%
ROICexc(5y)10.64%
ROICexgc(3y)16.14%
ROICexgc(5y)16.08%
ROCE(3y)13.07%
ROCE(5y)14.22%
ROICexgc growth 3Y8.15%
ROICexgc growth 5Y10.63%
ROICexc growth 3Y3.74%
ROICexc growth 5Y2.76%
OM growth 3Y4.55%
OM growth 5Y6.44%
PM growth 3Y-1.1%
PM growth 5Y2.27%
GM growth 3Y5.26%
GM growth 5Y3.2%
F-Score7
Asset Turnover0.83
Health
Industry RankSector Rank
Debt/Equity 0.28
Debt/FCF 4.33
Debt/EBITDA 1.02
Cap/Depr 67.78%
Cap/Sales 1.78%
Interest Coverage 11.7
Cash Conversion 34.78%
Profit Quality 42.47%
Current Ratio 2.94
Quick Ratio 1.19
Altman-Z 4.47
F-Score7
WACC8.9%
ROIC/WACC1.48
Cap/Depr(3y)78.22%
Cap/Depr(5y)67.78%
Cap/Sales(3y)2.14%
Cap/Sales(5y)1.86%
Profit Quality(3y)77.16%
Profit Quality(5y)84.08%
High Growth Momentum
Growth
EPS 1Y (TTM)24.23%
EPS 3Y23.06%
EPS 5Y20.72%
EPS Q2Q%-1.36%
EPS Next Y0.95%
EPS Next 2Y5.42%
EPS Next 3Y-0.14%
EPS Next 5Y6.46%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%0.78%
Revenue Next Year5.43%
Revenue Next 2Y5.1%
Revenue Next 3Y5.65%
Revenue Next 5Y5.64%
EBIT growth 1Y25.27%
EBIT growth 3Y19.51%
EBIT growth 5Y22.59%
EBIT Next Year38.49%
EBIT Next 3Y14.14%
EBIT Next 5YN/A
FCF growth 1Y-8.15%
FCF growth 3Y33.52%
FCF growth 5Y23.87%
OCF growth 1Y-11.46%
OCF growth 3Y32.07%
OCF growth 5Y19.38%

DORMAN PRODUCTS INC / DORM FAQ

What is the ChartMill fundamental rating of DORMAN PRODUCTS INC (DORM) stock?

ChartMill assigns a fundamental rating of 6 / 10 to DORM.


Can you provide the valuation status for DORMAN PRODUCTS INC?

ChartMill assigns a valuation rating of 4 / 10 to DORMAN PRODUCTS INC (DORM). This can be considered as Fairly Valued.


What is the profitability of DORM stock?

DORMAN PRODUCTS INC (DORM) has a profitability rating of 9 / 10.


Can you provide the financial health for DORM stock?

The financial health rating of DORMAN PRODUCTS INC (DORM) is 6 / 10.


How sustainable is the dividend of DORMAN PRODUCTS INC (DORM) stock?

The dividend rating of DORMAN PRODUCTS INC (DORM) is 0 / 10 and the dividend payout ratio is 0%.